Dr. Tina Sampalis, M.D., Ph.D., joined Neptune Technologies in 2000 and holds the position of Chief Global Strategy Officer. Dr. Sampalis is an Oncology Surgeon trained in Physiology at McGill University, Medicine at the University of Patras (Greece), Dermatology at Göttingen University (Germany) and Marselisborg University (Denmark), Pediatric, General and Oncology Surgery at the University of Athens (Greece), graduate training (Ph.D.) in Surgical Research at the University of Athens and a second Ph.D. in Epidemiology and Experimental Surgery at McGill University. She has received several international scholarships and awards for her work on the clinical implementation of retinols for skin and breast cancer, including the Helen Hutchison Award for geriatric medicine. Her work on scintimammography resulted in her appointment at the International Educational Speakers Bureau, the Canadian and U.S. Faculty of Medical Speakers for Breast Imaging. As an international scholar she leads the development and implementation of innovative micro-invasive and stereotactic robotic surgical techniques for breast cancer, for which a U.S. and Canadian patent application has been filed. She is a member of the American Association of Naturopathic Medicine. Dr. Sampalis has published in multiple peer reviewed publications.

Mr. André Godin, C.A., has a Bachelor’s Degree in Administration and has been a Member of the Canadian Institute of Chartered Accountants since 1988. He has more than 10 years’ experience in the Biotech/Pharma industry as former President of a dietary supplement company and as a Corporate Controller for a pharmaceutical company in OTC products. Mr. Godin has been Vice-President, Administration and Finance for Neptune Technologies and Bioressources Inc. since 2003.

Dr. Wael Massrieh joined Neptune in 2007 and currently holds the position of Vice-President of Scientific Affairs. He completed his Bachelor of Science in Microbiology and Immunology at McGill University, where he then pursued his Doctorate in Medicine, in the division of Experimental Medicine, specializing in proteins that regulate inflammation. His interest in omega-3 research started during his doctorate, after several articles had shown that there was a link between diets that were low in omega-3 fatty acids and increased risk of preterm birth. This eventually introduced him to Neptune Krill Oil™ and its rich source of novel omega-3 phospholipids.

Mr. Michel Timperio currently holds the position of Vice-President of Global Sales at Neptune. He has been employed by Neptune since 2010, but was a member of the Board of Directors from 2000 to 2008. Mr. Timperio has many years of experience in sales. He obtained his Bachelor of Commerce at Concordia University in Montreal, Quebec. With a natural entrepreneurial character, he launched his own distributing business. Many years after, Mr. Timperio also built a start-up venture in residential construction from 2001–2010. He also worked for large corporations such as Armstrong World Industries and Reichhold Chemicals, where he held senior management business development positions. Mr. Timperio has also had a political career for six years.